购物车
- 全部删除
- 您的购物车当前为空
ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.
ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 | |
100 mg | 询价 | 10-14周 |
产品描述 | ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment. |
分子量 | 1461.66 |
分子式 | C71H100N18O16 |
CAS No. | 2040964-58-5 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容